MaxCyte MXCT Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $14.56M-37.8% | $20.07M-28.0% | $12.97M-64.9% | $15.23M-59.4% | $23.39M+5.1% | ||
| $92.3M-19.7% | $82.98M-34.5% | $92.76M-20.6% | $111.34M-7.1% | $114.89M-15.1% | ||
| $4.25M-23.1% | $3.5M-25.2% | $8.31M+82.1% | $5.75M+25.6% | $5.53M-7.8% | ||
| $7.63M-7.8% | $7.55M-15.3% | $7.61M-26.8% | $7.93M-28.9% | $8.27M-30.8% | ||
| $122.94M-21.1% | $118.37M-31.1% | $124.65M-27.9% | $143.22M-18.5% | $155.75M-12.8% | ||
| $16.64M-16.5% | $17.53M-11.0% | $18.62M-11.2% | $19.4M-10.7% | $19.92M-12.6% | ||
| $783K+57.2% | $650K— | $667K— | $638K— | $498K— | ||
| $194.47M-15.4% | $202.51M-15.4% | $213.48M-14.1% | $219.75M-12.6% | $229.96M-10.8% | ||
| $1.2M-47.5% | $1.4M+3.2% | $1.29M-31.0% | $1.21M+27.0% | $2.28M+36.1% | ||
| $3.27M-21.1% | $3.6M-31.5% | $5.2M-21.9% | $2.64M-21.6% | $4.15M-7.4% | ||
| $10.21M-19.8% | $14.27M-9.6% | $16.1M-8.6% | $11.56M-5.9% | $12.73M-5.5% | ||
| $26.59M-13.0% | $31.02M-6.6% | $33.2M-6.0% | $29.03M-4.0% | $30.55M-3.2% | ||
| $1.07M+0.8% | $1.07M+1.0% | $1.07M+1.2% | $1.07M+1.7% | $1.06M+1.8% | ||
| -$266.23M-17.2% | -$261.48M-20.6% | -$251.89M-22.1% | -$239.47M-23.0% | -$227.11M-22.5% | ||
| $167.89M-15.8% | $171.49M-16.9% | $180.28M-15.5% | $190.72M-13.8% | $199.41M-11.9% | ||
| $194.47M-15.4% | $202.51M-15.4% | $213.48M-14.1% | $219.75M-12.6% | $229.96M-10.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are MaxCyte's total assets?
- MaxCyte (MXCT) holds $194.5M in total assets, down 15.4% year over year.
- How much debt does MaxCyte have?
- MaxCyte carries $17.5M in total debt against $167.9M of shareholders' equity, a debt-to-equity ratio of 0.10.
- How much cash does MaxCyte have?
- MaxCyte holds $14.6M in cash and equivalents.
- Can MaxCyte cover its short-term obligations?
- Its current ratio is 12.04 — current assets exceed current liabilities.
- Where does MaxCyte's balance sheet data come from?
- Every line is extracted from MaxCyte's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
